C/EBPα expression is associated with homeostasis of the gastric epithelium and with gastric carcinogenesis

Laboratory Investigation

Volumn 90, Issue 8, 2010, Pages 1132-1139

  Regalo, Gonçalo ^a,b   Resende, Carlos ^a   Wen, Xiaogang ^a   Gomes, Bárbara ^a,b   Dures, Cecília ^a   Seruca, Raquel ^a,b   Carneiro, Fátima ^a,b   MacHado, José C ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b University of Porto   (Portugal)

Author keywords

C EBP ; C EBPa; gastric cancer; stomach; TFF1

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; CYCLIN D1; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P27; RAS PROTEIN; TREFOIL FACTOR 1; TREFOIL PEPTIDE; TUBULIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER MODEL; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; GENETIC TRANSFECTION; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; STOMACH EPITHELIUM; TUMOR SUPPRESSOR GENE;

ADULT; CARCINOMA; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CCAAT-ENHANCER-BINDING PROTEINS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GASTRIC MUCOSA; HOMEOSTASIS; HUMANS; MALE; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

EID: 77955147186     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2010.79     Document Type: Article

References (17)

1. Peek Jr RM, Crabtree JE. Helicobacter infection and gastric neoplasia. J Pathol 2006;208:233-248.
2. Nerlov C. The C/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control. Trends Cell Biol 2007;17:318-324.
3. Regalo G, Canedo P, Suriano G, et al. C/EBPbeta is over-expressed in gastric carcinogenesis and is associated with COX-2 expression. J Pathol 2006;210:398-404.
4. Dossinger V, Kayademir T, Blin N, et al. Down-regulation of TFF expression in gastrointestinal cell lines by cytokines and nuclear factors. Cell Physiol Biochem 2002;12:197-206.
5. Ramji DP, Foka P. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J 2002;365:561-575.
6. Rosen ED. The transcriptional basis of adipocyte development. Prostaglandins Leukot Essent Fatty Acids 2005;73:31-34.
7. Payne VA, Au WS, Gray SL, et al. Sequential regulation of diacylglycerol acyltransferase 2 expression by CAAT/enhancer-binding protein beta (C/EBPbeta) and C/EBPalpha during adipogenesis. J Biol Chem 2007;282:21005-21014.
8. Tang QQ, Zhang JW, Daniel Lane M. Sequential gene promoter interactions by C/EBPbeta, C/EBPalpha, and PPARgamma during adipogenesis. Biochem Biophys Res Commun 2004;318:213-218.
9. Pabst T, Mueller BU, Zhang P, et al. Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia. Nat Genet 2001;27: 263-270.
10. Schuster MB, Porse BT. C/EBPalpha: a tumor suppressor in multiple tissues? Biochim Biophys Acta 2006;1766:88-103.
11. Costa DB, Li S, Kocher O, et al. Immunohistochemical analysis of C/EBPalpha in non-small cell lung cancer reveals frequent down-regulation in stage II and IIIA tumors: a correlative study of E3590. Lung Cancer 2007;56:97-103.
12. Tada Y, Brena RM, Hackanson B, et al. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer. J Natl Cancer Inst 2006;98:396-406.
13. Brennetot C, Duval A, Hamelin R, et al. Frequent Ki-ras mutations in gastric tumors of the MSI phenotype. Gastroenterology 2003;125:1282.
14. Nerlov C. C/EBPalpha mutations in acute myeloid leukaemias. Nat Rev Cancer 2004;4:394-400.
15. Gery S, Tanosaki S, Bose S, et al. Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer. Clin Cancer Res 2005;11:3184-3190.
16. Shim M, Powers KL, Ewing SJ, et al. Diminished expression of C/EBPalpha in skin carcinomas is linked to oncogenic Ras and reexpression of C/EBPalpha in carcinoma cells inhibits proliferation. Cancer Res 2005;65:861-867.
17. Resende C, Regalo G, Durães C, et al. Genetic changes of CEBPA in cancer: mutations or polymorphisms? J Clin Oncol 2007;25: 2493-2494.